Introduction {#section0005}
============

Since the identification of a novel coronavirus associated with severe acute respiratory syndrome (SARS), and the discovery of new human coronaviruses such as HCoV-NL63 and HCoV-NH, associated with respiratory illnesses, the interest on coronaviruses has clearly increased ([@bib15], [@bib16], [@bib28], [@bib59]). The design of antiviral drugs interfering with coronavirus replication ([@bib21]) and the development of replication-competent propagation-deficient virus vectors ([@bib42]) are potential powerful tools to prevent and control coronavirus infections.

Transmissible gastroenteritis coronavirus (TGEV) is a member of the *Coronaviridae* family within the Nidovirales order ([@bib13]). TGEV is an enveloped virus with a single-stranded, positive-sense RNA genome of 28.5 kb. About two-thirds of the genome encode the replicase gene, which comprises open reading frames 1a and 1b, the last one being expressed by ribosomal frameshifting ([@bib6], [@bib44]). The 3′ one-third of the genome includes structural and nonstructural genes, in the order 5′-S-3a-3b-E-M-N-7-3′ ([@bib12]).

In the *Coronaviridae* family, the viral envelope contains at least three structural proteins. The most abundant is the membrane (M) protein, spanning the membrane three or four times and interacting with the nucleocapsid (N) and spike (S) proteins during assembly ([@bib14], [@bib48]). The second most abundant is the S protein, a large type I-transmembrane glycoprotein that forms peplomers and is responsible for cell receptor binding and membrane fusion ([@bib33], [@bib53], [@bib54], [@bib55]). The third is the small envelope (E) protein, a transmembrane protein detected as a minor structural component in TGEV, mouse hepatitis virus (MHV), SARS-CoV, and avian infectious bronchitis virus (IBV) ([@bib19], [@bib36], [@bib51], [@bib66]). Another essential constituent of the virion is the N protein, an internal phosphoprotein that interacts with the genomic RNA to form the viral nucleocapsid ([@bib14], [@bib26], [@bib41]).

Coronavirus maturation takes place at the *cis*-Golgi network also known as endoplasmic reticulum-Golgi intermediate compartment (ERGIC) ([@bib49], [@bib57], [@bib58]). The E protein plays an important role during virus budding and transiently resides in a pre-Golgi compartment before progressing to the Golgi apparatus ([@bib8], [@bib38], [@bib45]). It has been proposed that the E protein induces virus envelope curvature in pre-Golgi membranes during MHV and SARS-CoV infections ([@bib3], [@bib31]). Studies on the assembly of coronavirus structural proteins by heterologous mammalian expression systems have shown that coexpression of E and M proteins from bovine coronavirus (BCoV), MHV, TGEV, IBV, and SARS-CoV results in the formation of virus like-particles (VLPs) that are morphologically identical to spikeless virions ([@bib4], [@bib8], [@bib22], [@bib32], [@bib40], [@bib61]). In addition, it has been described that both the MHV and IBV E proteins are sufficient for the generation of VLPs ([@bib8], [@bib38]). These observations suggested that neither the N nor the S proteins are needed for viral budding. In contrast, recent studies ([@bib23]) described that M and N proteins are necessary and sufficient for the formation of SARS-CoV pseudoparticles. Therefore, the role of E protein in coronavirus morphogenesis requires additional studies.

The construction of coronavirus full length cDNA clones ([@bib2], [@bib7], [@bib56], [@bib64], [@bib65]) or strategies of targeted recombination ([@bib27], [@bib30], [@bib39]) have allowed the manipulation of viral genomes to study coronavirus morphogenesis. Recently, a recombinant MHV virus with the entire gene E deleted was constructed ([@bib29]). This virus replicates with a low infectious titer, indicating that E protein is critical, but not essential for MHV replication in vitro. At variance, our laboratory has described an essential role for the E protein during TGEV replication. rTGEV-ΔE virus was rescued by complementation within E^+^ packaging cell lines ([@bib42]).

In this article, we confirm that E protein is essential for TGEV replication in different cell lines, and report the first evidence that TGEV virions containing RNA are generated in absence of E protein, although virus maturation was arrested in the budding compartment, and immature virions were accumulated between the rough endoplasmic reticulum and *cis*-Golgi. These results provide evidence of an essential role of the E protein during TGEV morphogenesis and in the intracellular virus trafficking through the secretory pathway.

Results {#section0010}
=======

Requirement of E protein for the generation of infective rTGEV-ΔE virus {#section0015}
-----------------------------------------------------------------------

A replication-competent propagation-deficient rTGEV-ΔE virus has been developed. This virus was rescued by complementation within E^+^ packaging cell lines ([@bib42]). To determine whether TGEV propagation deficiency was dependent on the infected cell line, a collection of E^−^ cell lines permissive for TGEV replication (ST, CRFK, BHK-pAPN, and LLC-PK1) were infected with rTGEV-ΔE. Virus production was undetectable in infected BHK-pAPN, LLC-PK1, ST, and CRFK E^−^ cell lines either after 48 h post-infection or during four consecutive cell passages. In contrast, infection with rTGEV-ΔE of E^+^ cell lines produced infective virus, with titers up to 10^7^ pfu/ml in BHK-pAPN-E^+^ and 10^6^ pfu/ml in LLC-PK1-E^+^. These data indicated that the lack of infectious rTGEV-ΔE virus production was independent of the cell line.

To confirm the propagation deficiency of rTGEV-ΔE, ST-E^−^ cells were infected with this virus and the propagation analyzed by plaque assay and immunofluorescence microscopy. Lysis plaques were observed in monolayers of ST-E^−^ cells infected with rTGEV-wt at 24 h post-infection, whereas no plaques were generated by rTGEV-ΔE in these cells up to 96 h post-infection ([Fig. 1](#fig1){ref-type="fig"} ). Immunofluorescence microscopy of ST-E^−^ cells infected at low m.o.i. (0.05) showed groups of cells infected by rTGEV-wt at 16 h post-infection. In contrast, single infected ST-E^−^ cells were observed in monolayers infected with rTGEV-ΔE virus ([Fig. 1](#fig1){ref-type="fig"}) at the same time post-infection and, later in the infection, the cells died and the fluorescence disappear (data not shown), suggesting that ΔE virions did not spread to neighboring uninfected cells and confirming that rTGEV-ΔE was a replication-competent propagation-deficient virus.Fig. 1Lack of rTGEV-ΔE propagation in E^−^ cell lines. Analysis of virus propagation in rTGEV-wt and rTGEV-ΔE infected ST-E^−^ cells at 24 and 96 h p.i., respectively, by plaque assay and immunofluorescence microscopy at 16 h p.i. using a TGEV specific serum. Mock, non-infected cells.

Formation of TGEV virions in the absence of E protein {#section0020}
-----------------------------------------------------

BHK-pAPN-E^+^ and E^−^ cells infected with rTGEV-ΔE virus were analyzed by electron microscopy to determine the formation of TGEV virions. Mature forms of the virions showing a dense core (60-nm diameter), preferentially located inside secretory vesicles, were abundant in infected BHK-pAPN-E^+^ cells at 24 h post-infection ([Figs. 2](#fig2){ref-type="fig"}A, E^+^ ), whereas large virus-like particles, exhibiting an electron dense periphery and a translucent central zone, were unexpectedly observed in infected BHK-pAPN-E^−^ cells at the same time post-infection ([Figs. 2](#fig2){ref-type="fig"}A, E^−^). These large virus-like particles resembled the TGEV immature virions previously reported ([@bib47]) but with a higher diameter (larger than 80-nm). Mature intracellular virions were not observed in rTGEV-ΔE infected BHK-pAPN-E^−^ cells.Fig. 2Characterization of intracellular and extracellular rTGEV-ΔE virus in BHK-pAPN-E^+^ and E^−^ cells. (A) Assembly characterization of rTGEV-ΔE in BHK-pAPN-E^+^ and E^−^ cells by electron microscopy. Panels show sections from rTGEV-ΔE infected BHK-pAPN-E^+^ and E^−^ cells at 24 h p.i. Scale bars, 300 nm. (B) The presence of TGEV proteins in supernatants was analyzed by SDS-PAGE using 5 to 20% gradient gels and silver staining. The arrows to the right of the panel indicate the positions of TGEV structural proteins. (C) Electron micrographs of virions from supernatants of rTGEV-ΔE infected BHK-pAPN-E^+^ and E^−^ cells concentrated 200-fold, and stained with 2% uranyl acetate are shown. Scale bar, 100 nm.

To determine whether mature or immature virions were secreted from rTGEV-ΔE infected BHK-pAPN-E^−^ cells, the presence of virions in the supernatants of infected BHK-pAPN-E^+^ and E^−^ cells was analyzed after virion purification by silver-staining SDS-PAGE and negative-staining electron microscopy ([Fig. 2](#fig2){ref-type="fig"}). No structural TGEV proteins were detected in the supernatants of BHK-pAPN-E^−^ cells infected with rTGEV-ΔE at 48 h post-infection, whereas S, M, and N proteins were detected in the supernatants of infected cells expressing E protein ([Fig. 2](#fig2){ref-type="fig"}B). The absence of secreted virions in BHK-pAPN-E^−^ cells infected with rTGEV-ΔE was confirmed by negative-staining electron microscopy on 200-fold concentrated supernatants, whereas virions were observed in supernatants of BHK-pAPN-E^+^ infected cells ([Fig. 2](#fig2){ref-type="fig"}C). These observations demonstrated that rTGEV-ΔE infected BHK-pAPN-E^−^ cells did not secrete mature or immature virions.

Immunochemical characterization of rTGEV-ΔE virions {#section0025}
---------------------------------------------------

The composition of the large immature viral particles assembled in BHK-pAPN-E^−^ cells was determined by immunogold detection in sections of freeze-substituted samples. MAbs specific for S, M, and N proteins provided a positive signal on the rTGEV-wt and rTGEV-ΔE virions assembled on BHK-pAPN-E^−^ cells, whereas only the rTGEV-wt virions bound the MAb specific for E protein, as expected ([Fig. 3](#fig3){ref-type="fig"}A).Fig. 3Characterization of rTGEV-ΔE virions by immunoelectron microscopy. rTGEV-wt (WT) or rTGEV-ΔE (ΔE) infected BHK-pAPN-E^−^ cells at 24 h p.i. are shown. MAbs specific for the TGEV structural proteins S, M, N, and E (A) and a complex of RNase and colloidal gold (B) were used. Panel A shows samples processed by freeze-substitution in methanol. Panel B shows samples embedded in EML-812. The specificity of RNase-gold labeling (+) was assessed with RNase-treated negative controls (−). Colloidal gold conjugates 10 nm in diameter were used for panels A and B. Scale bars, 100 nm. Mock, non-infected cells. RER, rugose endoplasmic reticulum.

To study whether rTGEV-ΔE virions incorporated RNA, BHK-pAPN-E^−^ cells infected with rTGEV-ΔE or rTGEV-wt were analyzed by RNase-gold electron microscopic cytochemistry. RNase-gold complex showed similar binding levels to virions assembled on BHK-pAPN-E^−^ cells infected with rTGEV-ΔE or rTGEV-wt ([Fig. 3](#fig3){ref-type="fig"}B(+)) indicating that the rTGEV-ΔE virions incorporated RNA. Binding of RNase-gold to ribosomes of the rough endoplasmic reticulum (RER) was also clearly observed ([Fig. 3](#fig3){ref-type="fig"}B(+)), whereas the RNase-treated negative controls lacked any labeling either on ribosomes or on viral particles ([Fig. 3](#fig3){ref-type="fig"}B(−)), confirming binding specificity.

Intracellular localization of TGEV structural proteins in BHK-pAPN-E^−^ cells infected with rTGEV-ΔE {#section0030}
----------------------------------------------------------------------------------------------------

The intracellular localization of TGEV structural proteins was studied in BHK-pAPN-E^−^ and E^+^ cells infected with the rTGEV-ΔE by indirect immunofluorescence using MAbs specific for TGEV S, M, N, and E proteins. The immunofluorescent signal associated with the TGEV structural proteins M, N, and S was similar in BHK-pAPN-E^−^ and E^+^ cells ([Fig. 4](#fig4){ref-type="fig"} ) with some significative differences. Thus, proteins S and M were accumulated in the perinuclear region in infected BHK-pAPN-E^−^ cells, whereas specific signals for these two proteins were extended to the cytoplasm in infected BHK-pAPN-E^+^ cells. Immunofluorescence specific for N protein was observed in the cytoplasm of BHK-pAPN-E^−^ and E^+^ cells but, in addition, a punctuate immunofluorescence pattern that corresponded to the accumulation of secretory vesicles in late infection stages was also observed in BHK-pAPN-E^+^ cells ([@bib49]). The changes observed in the subcellular localization of the TGEV structural proteins, in the absence of E protein, suggested an arrest in TGEV intracellular transport, whereas in BHK-pAPN-E^+^ cells rTGEV-ΔE virions progressed through the Golgi to release from the cell by exocytosis.Fig. 4Detection of TGEV structural proteins in rTGEV-ΔE infected BHK-pAPN-E^+^ and E^−^ cells by immunofluorescence. TGEV structural proteins were detected by immunofluorescence using MAbs specific for S, M, N, and E proteins in rTGEV-ΔE infected BHK-pAPN-E^+^ and E^−^ cells at 16 h p.i.

Previous studies ([@bib49]) suggested that TGEV morphological transformation from large immature particles into more condensed mature virus particles takes place during its transport along the exocytic pathway. To determine the effect of E gene deletion on TGEV infection of BHK-pAPN-E^−^ cells, the subcellular localization of virus particles and endoplasmic reticulum (protein disulfide-isomerase, PDI), intermediate compartment and *cis*-Golgi (KDEL receptor), and *trans*-Golgi (giantin) specific markers were compared by immunofluorescence laser scanning confocal microscopy in rTGEV-wt and rTGEV-ΔE infected BHK-pAPN-E^−^ and E^+^ cells at different times post-infection (0, 8, 14, and 24 h post-infection). The immunofluorescence pattern observed with endoplasmic reticulum markers was similar in BHK-pAPN-E^+^ and E^−^ cells infected with rTGEV-wt or rTGEV-ΔE, and in non-infected cells, at all the time points analyzed, indicating that the overall distribution of this organelle in the cell cytoplasm was not significantly affected by any of these two viruses ([Fig. 5](#fig5){ref-type="fig"} ). Only the time points 0 and 24 h are shown for simplicity.Fig. 5Detection of the endoplasmic reticulum marker PDI and rTGEV in BHK-pAPN-E^+^ and E^−^ cells by immunofluorescence. TGEV infection and protein disulfide isomerase (PDI) were monitored in BHK-pAPN-E^+^ and E^−^ cells infected with rTGEV-wt and rTGEV-ΔE at 0 and 24 h p.i. by immunofluorescence microscopy using a rabbit polyclonal antibody specific for PDI and a TGEV M protein specific MAb.

KDEL receptor immunofluorescence specific signal in the intermediate compartment and *cis*-Golgi was almost undetectable in rTGEV-wt infected BHK-pAPN-E^−^ and E^+^ cells ([Fig. 6](#fig6){ref-type="fig"} ). In contrast, the KDEL receptor specific signal in BHK-pAPN-E^−^ cells infected with rTGEV-ΔE showed a progressive and strong accumulation at 24 h post-infection ([Fig. 6](#fig6){ref-type="fig"}). Immunoblots were performed and an increase in the amount of KDEL-R was observed in rTGEV-ΔE infected E^−^ cells, consistent with the result obtained by confocal microscopy (data not shown). Similar effect has been described ([@bib49]) when TGEV infection is blocked with monensin, a drug that selectively affects the Golgi complex interrupting the secretory pathway (data not shown). Furthermore, the infection with rTGEV-ΔE in presence of E protein provided in trans showed no accumulation of KDEL receptor ([Fig. 6](#fig6){ref-type="fig"}). These data indicated that the accumulation of ERGIC vesicles could be a consequence of a membrane trafficking blockade in the secretory pathway leading to the inhibition of TGEV morphogenesis in the absence of E protein.Fig. 6Detection of KDEL-R and rTGEV in BHK-pAPN-E^+^ and E^−^ cells by immunofluorescence. TGEV infection and the ERGIC marker KDEL-R were monitored in BHK-pAPN-E^+^ and E^−^ cells infected with rTGEV-wt and rTGEV-ΔE at 0 and 24 h p.i. by immunofluorescence microscopy using a rabbit polyclonal antibody specific for TGEV and a KDEL-R specific MAb.

Staining for the Golgi complex in approximately 90% of rTGEV-wt infected BHK-pAPN-E^+^ and E^−^ cells showed fragmentation and dispersion of Golgi membranes at 24 h post-infection ([Fig. 7](#fig7){ref-type="fig"} ), whereas this disruption of Golgi was observed in only 20% of rTGEV-ΔE infected BHK-pAPN-E^+^ cells at 24 h post-infection probably due to the delay in the infection progress. In fact, later in the infection, the disruption Golgi was up to 100% in rTGEV-ΔE infected BHK-pAPN-E^+^ (data not shown). In contrast, disorganization of Golgi was not observed in rTGEV-ΔE infected BHK-pAPN-E^−^ cells at the analyzed times, indicating that the virus maturation did not progress from ERGIC to *trans*-Golgi in the absence of E protein. Taken together, these data indicate an arrest in the virus maturation in ERGIC, which is the TGEV budding compartment ([@bib49]).Fig. 7Detection of giantin and rTGEV in BHK-pAPN-E^+^ and E^−^ cells by immunofluorescence. TGEV infection and the Golgi apparatus marker giantin (gig) were monitored in BHK-pAPN-E^+^ and E^−^ cells infected with rTGEV-wt and rTGEV-ΔE at 0 and 24 h p.i. by immunofluorescence microscopy using a rabbit polyclonal antibody TGEV specific and a giantin specific MAb.

To confirm that the virus particles were blocked in the ERGIC in the absence of E protein, immunoelectron microscopy was developed to analyze the markers of the membrane-bound compartments containing virus particles. A different specific marker for the intermediate compartment, ERGIC-53/p58, was used due to the reduced signal observed for KDEL-R. The antibody specific for ERGIC-53/p58 provided a positive signal on the vesicles containing rTGEV-ΔE virions assembled on ST-E^−^ cells ([Figs. 8](#fig8){ref-type="fig"}A and B), whereas cytoplasm areas without virus vesicles and nucleus lacked any labeling, confirming the antibody binding specificity ([Figs. 8](#fig8){ref-type="fig"}A and C).Fig. 8Immunoelectron microscopy of ERGIC in rTGEV-ΔE infected ST-E^−^ cells. Panel A and B show vesicles filled with viruses that react with the anti-ERGIC-53/p58 antibody, specific marker for the intermediate compartment. Panel C shows a detail of the cytoplasm and nucleus where ERGIC-53/p58 specific signal was not observed. ERGIC-53/p58 specific signal is indicated with arrows. v, viruses; N, nucleus. Scale bars, 100 nm.

Discussion {#section0035}
==========

It has been shown that E protein is essential for TGEV morphogenesis. In TGEV-ΔE infected BHK-pAPN-E^−^ cells virions containing RNA were assembled, virus transportation was arrested in the ERGIC and full virus maturation was blocked and mature infectious virus was not secreted to the extracellular medium.

Previous studies have shown that, in the group 2 coronavirus MHV and SARS-CoV ([@bib10], [@bib31], [@bib29]), E protein is not essential for virus replication, although ΔE defective mutants have a reduced growth in cell culture and in animal models. In contrast, for group 1 coronavirus TGEV, we and others ([@bib9], [@bib42]) have shown that cells transfected with an E gene-deleted TGEV infectious cDNA do not produce infectious virus. Similarly, a gene E knockout mutant of the arterivirus equine arteritis virus (EAV), is unable to produce infectious progeny ([@bib52]). Kuo and Masters have suggested that the apparent lethality of E gene knockouts in EAV and TGEV may reflect a slow infection kinetics of these viruses that would allow uninfected cells to overgrow infected cells and obscure the detection of ΔE mutants of some nidovirus ([@bib29]). Our results clearly showed, in this and in a previous publication ([@bib42]), that E protein is essential for TGEV replication and that no infectious virus was produced at all. A simple explanation is that these viruses belong to different CoV groups and have different assembly requirements. The generation of infectious rTGEV-ΔE virus was dependent on E protein expression and independent of the infected cell line. Thus, rTGEV-ΔE infected cells did not secrete virus to the extracellular medium, and the virus did not spread to neighboring uninfected cells, and therefore did not generate plaques in infected ST-E^−^ cells up to 96 h post-infection, confirming that rTGEV-ΔE is a propagation-deficient virus in the absence of E protein provided in trans. Furthermore, no virus amplification was observed using supernatants or cell extracts from BHK-pAPN-E^−^ cells infected with rTGEV-ΔE virus when used to infect fresh BHK-pAPN-E^+^ cells, although these cells could have amplified minute amounts of rTGEV-ΔE virus. These data confirmed that E protein was essential for TGEV virus replication. Therefore, a different behavior is shown by coronavirus from groups 1 and 2 in the requirement for E protein during virus assembly.

The requirement of E and M proteins for the formation of virus-like particles has been previously described ([@bib61]). Co-infection with recombinant baculoviruses showed that the membrane and envelope proteins are sufficient for the efficient formation of coronavirus VLPs ([@bib40]). In contrast, Huang and coworkers reported that two viral genes, encoding the SARS-CoV M and N proteins, are necessary and sufficient for formation of VLPs by cotransfection of expression plasmids ([@bib23]). This discrepancy could be explained by the different cell types used in these studies (insect Sƒ9 and human 293T cells, respectively). In our study, electron microscopy analysis of BHK-pAPN-E^−^ cells infected with rTGEV-ΔE demonstrated that only immature TGEV virions were assembled in the absence of E protein. These virions contained RNA, and also all the structural TGEV proteins (S, M, and N) except the deleted E protein. These results indicate that the E protein is essential for the formation of mature TGEV virions. In the absence of E protein, the assembled virions displayed a morphology different from the full-length virus, were non-infectious, accumulated in the cytoplasm of the infected cells, and were not released to the extracellular medium or transported to neighboring cells.

TGEV replication depends on the exocytic pathway to complete its morphogenesis ([@bib49]). Virions were assembled as large particles with annular morphology at perinuclear compartment of the cells, and changed their morphology into small dense virions during the transport along the exocytic route ([@bib47], [@bib58]). In cells infected with rTGEV-ΔE, an accumulation of the KDEL receptor and the lack of fragmentation and dispersion of Golgi membranes were observed in absence of E protein. These effects and rTGEV-ΔE virus assembly into mature particles were recovered by providing E protein in trans. In addition, immunoelectron microscopy studies with an intermediate compartment specific marker confirmed that, in the absence of the E protein, the maturation of the virus is arrested in the ERGIC. A similar effect has been described when TGEV infection is blocked with monensin, a drug that selectively affects the Golgi complex interrupting the secretory pathway. Monensin blocks the viral transport from ERGIC, leading to the accumulation of numerous large viral particles in dilated pre-Golgi ERGIC elements of vacuolar morphology ([@bib49]). The comparable deficiencies observed in viral morphogenesis in the absence of E protein and as a result of treatment with monensin suggest an aberrant assembly process due to the absence of E protein. In principle, E protein could act directly on the ERGIC and Golgi compartments, on the virus itself, or in both. It has been postulated that E protein prepares the membrane or other viral proteins occupying strategic positions within the budding pathways ([@bib49]), as proposed for small acylated glycoproteins of alphaviruses and orthomyxoviruses that also display ion channel activity ([@bib17], [@bib24], [@bib35], [@bib62], [@bib67]). The absence of E protein would inhibit the progression through the ERGIC-Golgi compartments, resulting in the accumulation of virions in the ERGIC and of the ERGIC itself.

E proteins from MHV and SARS-CoV have viroporin activity ([@bib34], [@bib37]). Viroporins act at late stages of the viral cycle promoting the exit of new virus particles from the cell ([@bib20]). The exact mechanism by which viroporins alter the permeability of the plasma membrane is unknown, and it is possible that this activity is displayed both at the plasma membrane and on cellular organelles ([@bib1], [@bib60]). Coronavirus E protein localizes in membranes of ERGIC, where it could modify their permeability, leading to the disruption of ion gradients at intracellular organelles ([@bib37]), facilitating the transport of the virions along the exocytic pathway and their maturation. The absence of this viroporin activity mediated by the E protein possibly leads to the arrest of the transport of virions through the secretory pathway, the accumulation of non-mature virions in ERGIG, and the absence of release of new infectious virus from the cell. The construction of E protein mutants affecting E protein ion channel activity could assess whether this postulate is correct.

E proteins from the different coronavirus groups show different channel selectivity. The E protein from the group 1 coronavirus HCoV-229E is K^+^ selective, whereas from the group 2 MHV and SARS-CoV, and group 3 coronavirus IBV, E protein is Na^+^ selective ([@bib63], [@bib62]). The diverse channel selectivity among the coronavirus groups could be translated in differences in the effect of E protein in the secretory pathway and may explain the discrepancies among the gene E-defective mutants from the three coronavirus groups, and why E protein is essential for replication of group 1 viruses and non-essential for replication of group 2 viruses. Additional analysis of the gene E-defective mutants during assembly is required to shed light on the functions of the E protein in coronavirus morphogenesis in the three virus groups of the *Coronaviridae* family.

In conclusion, the arrest of TGEV maturation and the accumulation of virions in the secretory pathway due to the absence of the E protein confirm that this protein is essential for TGEV transportation and morphogenesis. The ability to generate TGEV-ΔE mutants that are replication-competent but propagation-deficient by complementation in packaging cell lines, supports the potential use of these mutants as vaccine vectors.

Materials and methods {#section0040}
=====================

Virus and cells {#section0045}
---------------

Recombinant rTGEV-*Mlu*I--*Fse*I (rTGEV-wt) and rTGEV-Δ3abΔE (rTGEV-ΔE) ([@bib42], [@bib43]) were grown as described ([@bib25]). Baby hamster cells (BHK-21) stably transformed with the gene coding for the porcine aminopeptidase N (BHK-pAPN) ([@bib11]) were grown in Dulbecco\'s modified Eagle\'s medium (DMEM) supplemented with 2% fetal calf serum (FCS) containing Geneticin G418 (1.5 mg/ml) as a selector agent. Porcine kidney cells, LLC-PK1 (European Collection of Cell cultures no. 86121112), were grown in medium 199 supplemented with 2 mM glutamine and 10% FCS. Cat kidney cells, CRFK (ATCC CCL 94), were grown in DMEM supplemented with 2% FCS. BHK-pAPN-E^+^ and LLC-PK1-E^+^ cells were grown as described previously ([@bib42]). Standard virus titrations were performed in porcine swine testis (ST) cells. Titrations of virus with the E gene deleted were performed in LLC-PK1 cells expressing the E protein.

Antibodies {#section0050}
----------

The murine MAbs 1D.G3, 3B.B3, and 3B.D10, specific for TGEV S, M, and N proteins, respectively, have been previously described ([@bib18], [@bib46], [@bib50]). The murine MAb Q3, specific for TGEV E protein, was a kind gift of H. Laude (INRA, Jouy-en Josas, France). The rabbit serum specific for PDI and the murine MAb specific for giantin was generously provided by A. Nieto (Centro Nacional de Biotecnología, CSIC, Madrid, Spain) and M. Renz (Institute of Immunology and Molecular Genetics, Karlsruhe, Germany), respectively. The murine MAb specific for KDEL receptor and the rabbit polyclonal antibody specific for ERGIC-53/p58 were purchased from Stressgen Biotechnologies Corp. (Victoria, BC, Canada) and Sigma-Aldrich (St. Louis. MO, USA), respectively.

TGEV virion purification {#section0055}
------------------------

TGEV virions were sedimented through a 20% sucrose cushion in TEN (Tris--HCl 10 mM \[pH 7.4\], EDTA 1 mM, NaCl 1M) 0.2% Tween 20 by centrifugation in an SW28 Beckman rotor at 25,000 rpm for 2 h at 4 °C. Sucrose was removed and the pellet was washed with TEN. Pellet was recovered by suspending it in TEN-0.2% Tween 20 and sedimented by centrifugation in a SW 41 Beckman rotor for 1 h at 25,000 rpm. Virions were recovered by suspending the pellet in TNE (Tris--HCl 10 mM \[pH 7.4\], EDTA 1 mM, NaCl 100 mM) and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and silver staining or negative staining and electron microscopy.

Electron microscopy {#section0060}
-------------------

### Processing of infected cells for embedding in EML-812 for ultrastructural studies {#section0065}

Monolayers of BHK-pAPN cells expressing TGEV E protein and control cells were infected with rTGEV-*wt* or rTGEV-ΔE virus. The cells were fixed in situ at 12, 16, and 24 h post-infection with a mixture of 2% glutaraldehyde and 1% tannic acid in 0.4 M HEPES buffer (pH 7.2) for 2 h at room temperature. The fixed monolayers were removed from the dishes in the fixative and transferred to Eppendorf tubes. After centrifugation in a microcentrifuge, the cell pellets were washed with HEPES buffer and processed for embedding in EML-812 (Taab Laboratories, Berkshire, United Kingdom) as described ([@bib47]). The cells were post-fixed with a mixture of 1% osmium tetroxide and 0.8% potassium ferricyanide in distilled water for 1 h at 4 °C. After four washes with HEPES buffer, samples were incubated with 2% uranyl acetate, washed again, and dehydrated in increasing concentrations of acetone (50, 70, 90, and 100%) for 15 min each at 4 °C. Infiltration in the resin EML-812 was done at room temperature for 1 day. Polymerization of infiltrated samples was done at 60 °C for 2 days. Ultrathin (50- to 60-nm-thick) sections of the samples were stained with saturated uranyl acetate and lead citrate by standard procedures.

### Quick freezing and freeze-substitution of cells {#section0070}

Cultures of cells were subjected to a mild fixation with a solution of 4% paraformaldehyde containing 0.1% glutaraldehyde in PBS at 4 °C for 30 min. Small pellets of chemically fixed cells were cryoprotected with glycerol, applied to small pieces of filter paper, blotted, and quick frozen in liquid ethane. Vitrified specimens were transferred to a Reichert-Jung AFS freeze-substitution unit (Leica, Vienna, Austria) and maintained for 48 h at − 90 °C in a mixture of methanol and 0.5% (w/v) uranyl acetate. After freeze-substitution, samples were infiltrated in Lowicryl K4M (EML Laboratories) at − 30 °C and polymerized with UV light. Ultrathin sections of the samples were either stained or processed for immunogold labeling.

### Immunoelectron microscopy {#section0075}

Immunogold detection of TGEV proteins on ultrathin-sections of infected BHK-pAPN cells was performed at room temperature with MAbs specific for M, N, S, E, and ERGIC-53 proteins by established procedures ([@bib46]). Sections collected on Formvar coated gold electron microscopy grids were incubated for 30 min with Tris buffer-gelatin and then floated on drops of diluted primary antibodies for 75 min. After jet washing with PBS, samples were incubated for 45 min with secondary antibodies conjugated with 10-nm-diameter gold particles and washed again with PBS and distilled water. Samples were then allowed to dry on filter paper before being stained with saturated uranyl acetate for 25 min, followed by 1 min with lead citrate. All samples were analyzed with a JEOL 1200 EX II electron microscope.

For ultrastructural detection of RNA, a complex of RNase and 10-nm-diameter colloidal gold (EY Laboratories, San Diego, CA) was used as described previously ([@bib47]). Ultrathin sections from Epon-included samples were collected on gold electron microscopy (EM) grids covered with collodion and incubated for 40 min at room temperature with the gold conjugated RNase diluted 1:20 in PBS. After being washed with PBS and distilled water, samples were stained with uranyl acetate and lead citrate. To unmask viral RNA molecules, sections were subjected to a treatment before incubation with RNase-gold consisting on 15 min incubation at 37 °C with proteinase K (10 μg/ml in Tris-EDTA), washing with TE, 10 min fixation with 4% paraformaldehyde in PBS, washing again with PBS, and incubation for 10 min with 0.2 M NH~4~Cl. As a cytochemical control, some sections were pre-incubated for 30 min at 37 °C with a solution of non-conjugated RNase (20 μg/ml) before being treated with the RNase-gold conjugated.

### Negative staining of rTGEV-ΔE virions {#section0080}

Virus from supernatants of BHK-pAPN-E^+^ and E^−^ cells infected with rTGEV-ΔE virus, concentrated 200-fold, were analyzed by negative staining as described ([@bib5]). Briefly, samples were adsorbed to UV light-activated copper grids for 2 min at room temperature. Grids were washed two times in H~2~O ([@bib14]) and stained with 2% uranyl acetate for 1 min. Samples were visualized in a JEOL 1200 EXII transmission electron microscope.

Immunofluorescence {#section0085}
------------------

Cells were plated on glass coverslips. Infections were performed at an m.o.i. = 1 pfu/cell at 37 °C in DMEM containing 2% FCS. The inoculum was removed at 90 min and the cells were maintained in DMEM 2% FCS. At the times indicated, cells were washed with PBS and fixed by addition of 4% paraformaldehyde for 30 min at room temperature. For dual-labeling experiments in which, one primary antibody was derived from mouse and the other one from rabbit, both antibodies were combined in a PBS-FCS 20% diluent containing 0.2% Saponin (Superfos-Biosector, Vedback, Denmark). Antibodies were allowed to adsorb for 90 min at room temperature, and washed three times with PBS-FCS 2%. Cells were then incubated for 30 min at room temperature with a mixture of anti-rabbit and anti-mouse secondary antibodies conjugated to Alexa 488 or Alexa 594. The coverslips were washed five times with PBS-FCS 2%, mounted on glass slides, and analyzed with a Laser Scanning Confocal System Radiance 2100 (Bio-Rad) on a Zeiss Axiovert 200 microscope. Argon ion and He--Ne lasers at 488 and 543 nm were employed as excitation sources. Image acquisition was performed using LaserSharp2000 v.5 software.
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